当前位置:首页 - 行情中心 - 金城医药(300233) - 财务分析 - 现金流量表

金城医药

(300233)

  

流通市值:58.58亿  总市值:60.50亿
流通股本:3.72亿   总股本:3.84亿

现金流量表

报告期2025-09-302025-06-302025-03-312024-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金1,708,973,946.321,179,279,499.63578,120,274.52,930,947,832.98
  收到的税费返还7,687,320.756,006,474.872,878,811.4219,566,553.42
  收到其他与经营活动有关的现金54,969,876.9937,819,783.0717,515,968.4933,200,724.45
  经营活动现金流入小计1,771,631,144.061,223,105,757.57598,515,054.412,983,715,110.85
  购买商品、接受劳务支付的现金650,602,007.59457,323,403.98247,293,732.111,187,150,158.36
  支付给职工以及为职工支付的现金463,882,077.55339,477,303.84208,150,990.12626,189,540.81
  支付的各项税费143,315,303.14110,080,470.7749,828,338192,478,681.91
  支付其他与经营活动有关的现金329,649,494.21211,856,667.41101,807,386.13681,311,005.6
  经营活动现金流出小计1,587,448,882.491,118,737,846607,080,446.362,687,129,386.68
  经营活动产生的现金流量净额184,182,261.57104,367,911.57-8,565,391.95296,585,724.17
二、投资活动产生的现金流量:
  取得投资收益收到的现金---323,349.14
  处置固定资产、无形资产和其他长期资产收回的现金净额7,744,123.27,648,287.27,550,887.662,292,805.33
  收到的其他与投资活动有关的现金742,175,481.7490,799,553.67280,488,060.62349,827,811.99
  投资活动现金流入小计749,919,604.9498,447,840.87288,038,948.22412,443,966.46
  购建固定资产、无形资产和其他长期资产支付的现金74,302,639.6235,469,377.0517,561,108.78142,613,753.87
  投资支付的现金---4,000,000
  支付其他与投资活动有关的现金813,000,000490,000,000280,000,000350,145,929.29
  投资活动现金流出小计887,302,639.62525,469,377.05297,561,108.78496,759,683.16
  投资活动产生的现金流量净额-137,383,034.72-27,021,536.18-9,522,160.56-84,315,716.7
三、筹资活动产生的现金流量:
  吸收投资收到的现金---6,490,000
  其中:子公司吸收少数股东投资收到的现金---6,490,000
  取得借款收到的现金137,975,000126,975,000108,000,000239,000,000
  筹资活动现金流入小计137,975,000126,975,000108,000,000245,490,000
  偿还债务支付的现金271,245,193.26269,245,193.26112,273,663.89280,782,961.02
  分配股利、利润或偿付利息支付的现金160,296,069.32120,109,129.5560,229,300.44150,868,869.9
  其中:子公司支付给少数股东的股利、利润---19,198,200
  支付其他与筹资活动有关的现金1,425,2421,161,908958,33457,609,074.74
  筹资活动现金流出小计432,966,504.58390,516,230.81173,461,298.33489,260,905.66
  筹资活动产生的现金流量净额-294,991,504.58-263,541,230.81-65,461,298.33-243,770,905.66
四、汇率变动对现金及现金等价物的影响1,973,205.381,867,868.361,463,5855,963,880.28
五、现金及现金等价物净增加额-246,219,072.35-184,326,987.06-82,085,265.84-25,537,017.91
  加:期初现金及现金等价物余额878,484,110.4878,484,110.4878,484,110.4904,021,128.31
  期末现金及现金等价物余额632,265,038.05694,157,123.34796,398,844.56878,484,110.4
补充资料:
  净利润-44,966,077.75-207,735,344.13
  资产减值准备-8,134,729.93-31,237,432.35
  固定资产和投资性房地产折旧-123,515,309.38-248,285,236.01
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-123,515,309.38-248,285,236.01
  无形资产摊销-32,791,304.13-68,554,555.18
  长期待摊费用摊销-1,613,648.67-3,506,502.94
  处置固定资产、无形资产和其他长期资产的损失--388,847.35--1,454,864.3
  固定资产报废损失--80,388.22--98,723.86
  公允价值变动损失-143,866.15--86,537.6
  财务费用-4,271,753.33-12,514,185.31
  投资损失--967,435.41-1,665,130.72
  递延所得税-78,681.93-3,108,185.81
  其中:递延所得税资产减少-11,188,046.9-5,836,011.1
    递延所得税负债增加--11,109,364.97--2,727,825.29
  存货的减少--15,060,506.46--115,589,406.28
  经营性应收项目的减少-106,942,546.84--28,107,015.69
  经营性应付项目的增加--194,049,412.22--137,105,665.96
  现金的期末余额-694,157,123.34-878,484,110.4
  减:现金的期初余额-878,484,110.4-904,021,128.31
  现金及现金等价物的净增加额--184,326,987.06--25,537,017.91
公告日期2025-10-272025-08-212025-04-292025-03-28
审计意见(境内)标准无保留意见
TOP↑